New Pill Slashes “Bad” Cholesterol and Heart Attack Risk in Just 12 Weeks

A new cholesterol-lowering pill may offer a breakthrough for those at risk of heart attack and stroke. A major international study led by Monash University has revealed a promising new way to help protect people at high risk of heart attacks and strokes. Researchers found that a new cholesterol-lowering medication could be more effective and easier to use than current treatments. The study, known as the BROADWAY trial, tested a once-daily oral drug called Obicetrapib. Results showed that it significantly reduced levels of LDL cholesterol and lipoprotein(a), or Lp(a). Both are key contributors to heart disease and are often difficult...